BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $162,000 | -74.1% | 658,302 | -45.6% | 0.00% | – |
| Q2 2022 | $626,000 | -87.2% | 1,211,222 | -49.2% | 0.00% | – |
| Q1 2022 | $4,891,000 | -45.4% | 2,386,053 | +11.1% | 0.00% | – |
| Q4 2021 | $8,956,000 | -46.1% | 2,147,749 | +20.3% | 0.00% | – |
| Q3 2021 | $16,610,000 | -34.3% | 1,786,067 | +27.3% | 0.00% | -100.0% |
| Q2 2021 | $25,266,000 | +421000.0% | 1,402,891 | +92868.3% | 0.00% | – |
| Q1 2021 | $6,000 | – | 1,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |